Vestrant Injecton 250 mg/5 mL

Fulvestrant is a prescription hormonal therapy used primarily for the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. It belongs to a class of medicines called selective estrogen receptor degraders (SERDs), which work by blocking and reducing estrogen receptors in cancer cells, thereby slowing or stopping tumor growth. The injection is supplied as a sterile, clear solution containing 250 mg of fulvestrant in 5 mL and is administered intramuscularly by a healthcare professional, usually into the buttock muscle. Standard treatment often involves two injections to achieve a 500 mg dose according to the prescribed schedule. Fulvestrant may be used alone or in combination with targeted therapies such as CDK4/6 inhibitors. Common side effects include injection-site pain, nausea, fatigue, headache, hot flashes, and joint pain. Patients receiving this medication require regular medical monitoring to assess treatment response and liver function. The product should be stored refrigerated at 2°C to 8°C and protected from freezing.

Price: Rs. 77079.00

• Manufacturer
  A.J.MIRZA PHARMA(Pvt) Ltd
• Generic name
  Fulvestrant
• Pack size
  1 Vial injection
• Availability
  In stock
• Prescription required
  Yes